Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Other financing activities (2022 - 2023)

Praxis Precision Medicines (PRAX) has 2 years of Other financing activities data on record, last reported at -$4.5 million in Q3 2023.

  • For Q3 2023, Other financing activities fell 4213.76% year-over-year to -$4.5 million; the TTM value through Jun 2023 reached $4.6 million, changed N/A, while the annual FY2022 figure was $262000.0, 54.43% down from the prior year.
  • Other financing activities reached -$4.5 million in Q3 2023 per PRAX's latest filing, down from $4.5 million in the prior quarter.
  • Across five years, Other financing activities topped out at $4.5 million in Q2 2023 and bottomed at -$4.5 million in Q3 2023.